WCM
NVO

Weaver Capital Management’s Novo Nordisk NVO Stock Holding History

Weaver Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,298
Closed -$274K – 190
2024
Q3 		$274K Buy
2,298
+305
+15% +$40.7K 0.08% 148
2024
Q2 		$284K Buy
1,993
+53
+3% +$7.02K 0.09% 142
2024
Q1 		$249K Hold
1,940
– – 0.09% 135
2023
Q4 		$201K Buy
+1,940
New +$192K 0.08% 130

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Weaver Capital Management's NVO Position: Q4 2024 in Review

Weaver Capital Management sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,298 shares — an estimated $274K sold.

Weaver Capital Management first reported a position in NVO in Q4 2023 and held it in 4 quarters. The position peaked at $284K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Weaver Capital Management reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Weaver Capital Management sold 2,298 Novo Nordisk shares in Q4 2024, an estimated $274K.
  • Weaver Capital Management first reported a position in Novo Nordisk in Q4 2023 and held it in 4 quarters.
  • Weaver Capital Management's Novo Nordisk position peaked at $284K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Weaver Capital Management's 13F filing for Q4 2024, filed 27 Jan 2025.